David joined speakers Dean Follmann (NIAID), Laura Lee Johnson (U.S. Food and Drug Administration), and
Kelly Van Lancker (Ghent University) to discuss Trial Design and Analysis Methods for COVID-19 Treatment/Prevention at the ENAR 2021 Spring Meeting.
David’s talk covered his recent Biometrics publication on statistical methods for increasing power when evaluating novel COVID-19 treatments. Slides from the talk are available on David’s GitHub.
About David Benkeser
I’m an Assistant Professor of Biostatistics and Bioinformatics at Emory University’s Rollins School of Public Health primarily interested in research involving vaccines, machine learning, causal inference, and all things data science. I teach courses on statistical theory, causal inference, and tools for data science. Beyond that, I offer individualized consulting services for research in clinical medicine, public health, and beyond.
